Events

College Station, Texas – September 13, 2026 -- Matica Biotechnology, a Texas-based cell and gene therapy CDMO, has entered a collaboration with Bondwell Technologies to advance the latter's proprietary protein bioprocessing platform toward manufacturing readiness.

Matica Bio will provide development expertise to prepare Bondwell's technology for commercialization

Under the agreement, Matica Bio will support Bondwell Technologies, headquartered in College Station, in scaling its proprietary protein technology for bioprocessing and life science applications. The collaboration is designed to move Bondwell's platform closer to manufacturing readiness and future commercial deployment.

Dublin – – September 13, 2026 -- LUMA Vision has secured an expanded FDA clearance for VERAFEYE, its procedural intelligence platform for minimally invasive cardiac procedures, moving the company closer to a planned commercial launch in early 2027.

VERAFEYE now unifies digital anatomy creation, catheter tracking, and guidance on a single platform

The new clearance allows VERAFEYE to reconstruct 3D models of the left and right atria with CT-like accuracy using a single 360° imaging catheter that captures raw ultrasound data. The platform lets physicians visualize and document ablation delivery directly on the anatomy while maintaining continuous tracking of both imaging and ablation catheters through electromagnetic tracking and automated imaging.

Cambridge, Mass. – September 13, 2026 -- Marengo Therapeutics has completed enrollment in the monotherapy cohorts of its Phase 1/2 STARt-001 trial evaluating invikafusp alfa across eight distinct PD-1-resistant tumor types, with updated results selected for an oral presentation at the ESMO 2026 Congress in Madrid, October 23-27.

Trial enrollment closes across eight PD-1-resistant tumor types

The monotherapy cohorts covered patients with MSS colorectal cancer, PD-L1-negative non-small cell lung cancer and triple-negative breast cancer, among others resistant to checkpoint blockade. Enrollment continues in standard-of-care combination cohorts, while the company plans to name lead indications for focused development alongside the ESMO data release.

Bethesda, Md. – September 13, 2026 -- Centrus Energy Corp. [NYSE: LEU] has signed a definitive multi-year contract to supply high-assay, low-enriched uranium (HALEU) to Radiant, adding a new domestic fuel customer as deliveries are set to begin before the end of the decade.

Contract includes prepayments to fund Centrus enrichment build-out

The agreement adds Radiant to Centrus' HALEU customer backlog and includes prepayments to Centrus that will support the company's domestic commercial enrichment capacity program. The fuel will supply multiple Kaleidos microreactors as Radiant scales from its first test unit toward commercial and national security deployments.

Delray Beach – September 13, 2026 -- The global data center energy storage systems market is set to grow from $5.17 billion in 2026 to $10.48 billion by 2032, a 12.5% compound annual growth rate, according to a new MarketsandMarkets report.

AI and cloud expansion drive storage demand across hyperscale facilities

Hyperscale, colocation, and enterprise data centers serving BFSI, healthcare, manufacturing, e-commerce, and IT & telecommunications clients are reinforcing power infrastructure as AI workloads strain grid capacity. Cloud & hyperscale data centers are projected to post the fastest growth among data center types at a 14.8% CAGR through 2032, commanding the largest revenue share as operators scale computing capacity requiring uninterrupted power.

Toronto – – September 13, 2026 -- Denarius Metals Corp. (Cboe CA: DMET; OTCQX: DNRSF) has secured a preferential option from the Regional Government of Castilla and Leon to acquire up to 28 new mining grids covering approximately 800 hectares adjacent to its Toral Project in Spain, a move that would expand its total land position in the Leon Mining District to roughly 3,700 hectares. The company separately disclosed a maiden NI 43-101 Mineral Resource Estimate for the 100%-owned Toral Project, prepared by Resource Development Associates with an effective date of July 24, 2026.

Indianapolis – September 13, 2026 -- Corteva (NYSE: CTVA) and Belgium-based Globachem N.V. have signed a definitive agreement to launch a 50/50 joint venture aimed at developing and delivering new crop protection solutions for farmers in Europe and the Americas, with the deal expected to close in the fourth quarter of 2026.

Joint venture will pool late-stage pipeline technology from both parent companies

The independently operated JV will draw on late-pipeline to commercial-stage technology from Corteva and Globachem to develop, register and market new products. Resulting solutions may be commercialized independently by one or both parent companies once ready.

New products targeted for launch in the early 2030s

The venture builds on an existing multi-year partnership between the two companies. New solutions are expected to reach the market in the early 2030s through established commercial channels.

Ft. Lauderdale – September 13, 2026 -- Z Squared Inc. (Nasdaq: ZSQR) closed its all-stock acquisition of Paradox Data, LLC, gaining an energized computing campus in El Dorado, Arkansas, with an existing 8.0 MW electric service arrangement and a phased target of 150+ MW of AI-ready capacity.

Deal closes with zero cash and no debt financing

Z Squared paid entirely in stock for Paradox Data, LLC, acquired from Paradox Infrastructure LLC, incurring no cash outlay or debt at closing. The transaction hands the company its first owned, energized computing site, the Union County Campus, as it builds out an AI colocation business.

Seoul – September 13, 2026 -- SK keyfoundry has signed a long-term wafer supply agreement with Elmos Semiconductor SE that guarantees production capacity through 2037, extending an 18-year partnership between the Korean 8-inch foundry and the German automotive chipmaker.

The deal, signed during a ceremony in Frankfurt am Main, shifts the two companies' collaboration from 350nm to 130nm process technology, marking the first major node transition in nearly two decades of cooperation.

New 130nm platform enables deep-trench isolation for high-voltage automotive chips

SK keyfoundry's 130nm technology incorporates deep-trench isolation (DTI), which provides electrical separation and supports highly integrated, high-voltage circuit designs with low substrate current. The foundry positions this capability as the technical basis for a broader range of automotive semiconductor products developed with Elmos going forward.

Chicago – September 13, 2026 -- Alliant Credit Union, a $20 billion-asset institution with nearly 1 million members, has partnered with Blend Labs Inc. (NYSE: BLND) to launch a fully digital mortgage and home equity lending platform.

Members can move from instant prequalification to full application in minutes

The new system lets borrowers complete mortgage applications independently or with support from Alliant Loan Specialists. Dan Bauer, head of residential lending at Alliant, said the platform is designed to help members move quickly in a competitive housing market and deliver market-leading turn times from application to closing.

London and New York – September 13, 2026 -- Coinbase has selected ION's XTP for Event Contracts platform to handle clearing for Kalshi, the world's largest prediction market, as trading volumes in event-based contracts accelerate.

Platform processed one million Kalshi trades over Super Bowl weekend

ION and Coinbase began partnering in December 2025 to support Kalshi's event contract listings, with the three parties collaborating to expedite analysis, development and rollout. During the initial deployment phase, XTP demonstrated capacity to absorb a spike in activity, processing Kalshi's first one million trades during Super Bowl weekend.

Boulder, Colo. – September 13, 2026 -- Integral Consulting Inc. has acquired Heritage Environmental Consultants, a Western U.S.-based environmental planning, permitting, and scientific services firm, expanding its footprint in the Mountain West region.

Heritage adds ecological and permitting expertise to Integral's service portfolio

Heritage Environmental Consultants, founded in 2008, brings capabilities in wildlife biology, terrestrial and aquatic ecology, soil science, hydrology, water and air quality, and geographic information systems. The combined firms will offer clients integrated solutions spanning environmental planning, permitting, ecological science, and regulatory compliance from early project development through long-term implementation.

Vancouver – September 13, 2026 -- OceanaGold Corporation (TSX: OGC, NYSE: OGC) has lodged an application under New Zealand's Fast-track Approvals Act 2024 to extend the operating life of its Macraes gold mine from the current 2032 reserve horizon into the late 2030s.

OceanaGold targets late-2030s mine life through Phase 4 permitting

The Macraes Phase 4 Project (MP4) application, filed September 9, 2026, covers permitting for the existing reserve mine plan, development of the Southern Pit Innes Mills (SPIM) extension, extensions to the Golden Point Underground (GPUG), and flexibility to add further Mineral Resources to future production. Under New Zealand's 'one-stop shop' fast-track process, OceanaGold expects full permitting by mid-2027, subject to appeals. The company previously used the same mechanism to secure approval for its Waihi North Project in 2025.

Tucson – September 13, 2026 -- Delta Development Team (DDT) has launched BloodCOMM®, a cloud-based blood management platform designed to digitize and automate blood supply chain tracking for hospitals, blood centers, EMS agencies, and air medical providers.

Platform creates digital identity for every blood unit from collection to disposition

BloodCOMM® uses barcode scanning, AI-powered label recognition, and automated event tracking to monitor blood unit location, temperature, expiration status, inspections, transfers, and excursions throughout the product lifecycle. The system builds a digital cold chain of custody record, capturing patient identifiers, product details, and deviation history as events occur rather than reconstructing them from paper logs or spreadsheets after the fact.

Dallas – September 13, 2026 -- The U.S. Food and Drug Administration has accepted and filed the Biologics License Application for MOGENRY, an optogenetic gene therapy from Nanoscope Therapeutics designed to restore vision in retinitis pigmentosa patients with severe vision loss. If approved, MOGENRY would become the first gene-agnostic treatment available for this patient population, which currently has no approved therapy.

RESTORE trial data anchors the regulatory filing

The BLA is supported by the Phase 2b/3 RESTORE trial (NCT04945772), a multicenter, randomized, double-masked, sham-controlled study that met its primary and key secondary endpoints, showing improvements in visual acuity at weeks 52 and 76. No treatment-related serious adverse events were reported. Additional efficacy and safety data come from the earlier Phase 1/2a trial (NCT04919473).

Toronto – September 13, 2026 -- The Sales Factory has ranked #2 globally in the Outsourced Sales category of G2's Summer 2026 Grid Reports, marking the third consecutive quarter the outsourced sales and lead generation firm has held a top position on the review platform. The company also earned Leader status in the Lead Generation category, based entirely on verified customer reviews and market presence data compiled by G2.

G2 rankings rely solely on verified buyer reviews, not marketing spend

G2, described as the world's largest software and services marketplace, builds its quarterly Grid Reports from authenticated user reviews combined with market presence metrics. Leader status requires companies to sustain high customer satisfaction scores alongside demonstrated market traction, a methodology G2 says filters out purchased visibility.

Jacksonville, Fla. – September 13, 2026 -- Alan Alwakeel, a recent graduate of Stanton College Preparatory School, received a $3,000 Humane Science Award from the National Anti-Vivisection Society (NAVS) for an AI-powered cancer therapy simulation platform that eliminates the need for animal testing.

Platform simulates cancer treatment efficacy without animal trials

Alwakeel's project, "The Virtual Cell 2.0: Expanding Precision and Personalized Cancer Therapy Through AI-Powered Simulation," applies computational frameworks to evaluate potential cancer treatment outcomes. The tool aims to accelerate how new therapies are developed, tested and deployed by replacing traditional animal-based testing methods with data-driven simulation.

North Billerica, Mass. – September 13, 2026 -- Mass-Vac, Inc. has launched the MV Multi-Trap® Vacuum Inlet Trap, a high-capacity filtration unit for plastic extrusion lines that is field-proven to extend vacuum pump life by more than 12 years.

Extrusion byproducts threaten pump reliability across manufacturing lines

Volatile materials released during extruded plastic and composite processing can degrade vacuum pumps over time, driving unplanned downtime and maintenance costs for manufacturers. The new trap is designed to intercept these byproducts before they reach the pump, using a two-stage filtration system built from 304 stainless steel.

Two-stage filtration combines knockdown baffle with gauze filters

The device features a full first-stage knockdown baffle followed by a second stage of stainless steel gauze filters, with an optional bottom cooling feature. Mass-Vac offers the trap in 10

San Francisco – September 13, 2026 -- Cionic reported that the first 60 participants in its TRANSFORM study showed an average 26% improvement in health-related quality of life after one month, using the standardized EQ-5D-5L instrument across all five measured dimensions.

Cionic launches 12-month study tracking 1,000 adults with upper motor neuron conditions

The TRANSFORM study follows 1,000 adults with multiple sclerosis, stroke, spinal cord injury, cerebral palsy, and related conditions over 12 months, collecting quality-of-life data through six surveys administered via the Cionic mobile app at onboarding and at one, three, six, nine, and 12 months. The primary endpoint, EQ-5D-5L, measures mobility, self-care, usual activities, pain, and anxiety/depression, while secondary measures track spasticity, urinary incontinence, and fatigue.

Singapore – September 13, 2026 -- TÜV SÜD has opened its new Global Decarbonisation Centre of Excellence (CoE) in Singapore, backed by an investment exceeding $24 million with support from the Singapore Economic Development Board (EDB).

Investment builds on SustainCERT acquisition to scale digital carbon verification

The Munich-based testing and certification group launched the CoE following its recent acquisition of Luxembourg-based SustainCERT, an accredited validation and verification body specializing in digital measurement, reporting and verification (dMRV). The combined capabilities target carbon data integrity, carbon markets and independent assessment services as governments prepare to implement Article 6 of the Paris Agreement.